← Open Payments lookup

MARIE MAUGANS-COLEMAN: Open Payments

NPI 1730116070 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,604 in 79 payments from 11 companies in 2025. Trend: 2023 $1,527 · 2024 $1,355 · 2025 $1,604

Food & beverage: $1,604
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.22$414
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$375
Neurocrine BioSciences, Inc.11$229
Vanda Pharmaceuticals Inc.7$176
Janssen Pharmaceuticals, Inc5$119
ABBVIE INC.4$79
E.R. Squibb & Sons, L.L.C.4$76
Otsuka America Pharmaceutical, Inc.4$70
Alkermes, Inc.2$36
Vertical Pharmaceuticals, LLC1$15

Products named: CAPLYTA, UZEDY, INGREZZA, AUSTEDO XR, FANAPT, INVEGA SUSTENNA, VRAYLAR, COBENFY.

Industry payments across KS — which companies pay providers there.